Foundation Fighting Blindness Retinal Degeneration Fund
SEC insider (Form 3/4/5 filer). CIK 0002042266. Director at Opus Genetics, Inc. (IRD). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in RALEIGH, NC.
Companies Foundation Fighting Blindness Retinal Degeneration Fund has filed insider reports for
- Opus Genetics, Inc. (IRD): Director
Foundation Fighting Blindness Retinal Degeneration Fund
CIK: 0002042266
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (75.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IRD
Opus Genetics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 30, 2026IRD
Opus Genetics, Inc.
SaleDirect556K shares at avg. $4.96$2.8M - May 18, 2026IRD
Opus Genetics, Inc.
SaleDirect1.7M shares at avg. $4.35$7.4M - Dec 9, 2025IRD
Opus Genetics, Inc.
SaleDirect4M shares at avg. $2.15$8.6M - May 5, 2025IRD
Opus Genetics, Inc.
ConversionDirect6.9M shares-
1-4 of 4 transactions